Daily Bulletin

US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...

Read more: US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

Business News

The Importance of a Branding Agency for Your Business

Brand building is not only a logo or a catchy tagline. It's about how your business is seen, links with clients, and stands out in crowded markets. Whether you are a start-up or an established busin...

Daily Bulletin - avatar Daily Bulletin

Website Development Costs

When it comes to building a website, the scope and complexity of the project play a major role in determining the cost. Whether you need a simple landing page or a complex e-commerce platform, the...

Daily Bulletin - avatar Daily Bulletin

Major Steps to Take When Starting a Medical Billing Business

The healthcare industry continues to expand every day. If you have been thinking about starting a medical billing business, you are on the right track. This is a good business idea that can help you l...

Daily Bulletin - avatar Daily Bulletin